initial public offerings (IPOs) trading on American exchanges
Showing posts with label FVCB. Show all posts
Showing posts with label FVCB. Show all posts

Sunday, March 10, 2019

IPOs this week : March 11 - 15, 2019

IPO activity: The six-month lockup on shares of Nio (NYSE:NIO) expires on March 11 in what should be a good test of investor sentiment. Nio soared following a positive 60 Minutes piece about two weeks ago before going into post-earnings skid. Interestingly, Goldman Sachs came in with a reinstated Buy call on Nio ahead of the lockup expiration as it pointed to the Chinese automaker's "successful branding" in the premium segment.

Other lockup expirations this week include;

  • 111 (NASDAQ:YI) on March 11, 
  • FVC Bancorp (NASDAQ:FVCB) on March 12 and 
  • both Principia Biopharma (NASDAQ:PRNB) and Qutoutiao (NASDAQ:QTT) on March 13. 
Analysts can start covering TCR2 Therapeutics (NASDAQ:TCRR), Avedro (NASDAQ:AVDR), Achiano Therapeutics (NASDAQ:ANCN) and Imac (NASDAQ:IMAC) on March 11 and Stealth BioTherapeutics (NASDAQ:MITO) on March 12.

Friday, September 14, 2018

FVCBankcorp (FVCB) began trading on the Nasdaq on 14 September 2018


  • Headquarters: Fairfax, Virginia
  • Founded: 2015
  • Sector: Financial Services
  • Industry: Banks - Regional - US
  • Full Time Employees: 98
  • fvcbank.com

Priced 1.75 mln share IPO at $20.00, the midpoint of the expected $19.00-21.00 range